Ordinary Adjustment | Solactive Global Health Services & Technology Americas | Effective Date 16th October 2026

October 2, 2026

Announcement

Ordinary Adjustment | Solactive Global Health Services & Technology Americas | Effective Date 16th October 2026

Solactive Global Health Services & Technology Americas:

In the ordinary adjustment, the following composition will be implemented effective open 16th October 2026:

ABBOTT LABORATORIES
ABBVIE INC
ADDUS HOMECARE CORP
ANI PHARMACEUTICALS INC
BAUSCH + LOMB CORP
BECTON DICKINSON AND CO
BRISTOL-MYERS SQUIBB CO
CHEMED CORP
CIGNA GROUP
EDWARDS LIFESCIENCES CORP
ENCOMPASS HEALTH CORP
ENSIGN GROUP INC
EXTENDICARE INC
GILEAD SCIENCES INC
IDEXX LABORATORIES INC
IMMUNOCORE HOLDINGS PLC
INCYTE CORP
INMODE LTD
INNOVIVA INC
IRADIMED CORP
JAMIESON WELLNESS INC
JAZZ PHARMACEUTICALS PLC
JOHNSON & JOHNSON
LABCORP HOLDINGS INC
LANTHEUS HOLDINGS INC
MEDTRONIC PLC
MERIT MEDICAL SYSTEMS INC
PENUMBRA INC
PFIZER INC
QUEST DIAGNOSTICS INC
REGENERON PHARMACEUTICALS
ROYALTY PHARMA PLC- CL A
SIENNA SENIOR LIVING INC.
SOLVENTUM CORP
STERIS PLC
Sotera Health Co
THERMO FISHER SCIENTIFIC INC
UNITEDHEALTH GROUP INC
UNIVERSAL HEALTH SVS.B
VERTEX PHARMACEUTICALS INC
VIATRIS INC
WEST PHARMACEUTICAL SERVICES INC
ZIMMER BIOMET HOLDINGS INC
Index nameRICISIN
Solactive Global Health Services & Technology Americas Index NTR.SOLHCA1DE000SLA3GC0

Share your view and thoughts

We work closely with our internal partners to deliver investment ideas that generate demonstrable value for our clients.